tyrosine kinase inhibitor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New Trials
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Unknown (1)

Interventional (1)
Observational (1)

Huiqiang Huang (1)
The First Affiliated Hospital of Zhengzhou University (1)

No (2)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadanticoagulant therapy

I am/have/hadliver metastasis

I am/have/hadfollicular lymphoma grade iiib

I am/have/hadb-cell lymphoma

I am/have/hadthyroid dysfunction

I am/have/hadcreatinine clearance rate

I am/have/hadfollicular lymphoma

I am/have/hadtubal ligation

I am/have/hadvascular endothelial growth factor receptor 2

I am/have/hadebv-positive dlbcl, nos

I am/have/hadmeasurable disease

I am/have/hadvegf

I am/have/hadblood transfusion

I am/have/hadmetastasis

I am/have/hadglioma

I am/have/hadpulmonary function test

I am/have/hadhypertension

I am/have/hadimmunodeficiency

I am/have/hadtyrosine

I am/have/hadct scan

added new label for I am/have/had

more

I am looking for

I am looking forgranulocyte colony stimulating factor

I am looking foranticoagulants

I am looking for18f-fdg

I am looking forapatinib

I am looking fororal contraceptives

I am looking forrituximab

I am looking forgrowth factor

I am looking forg-csf

I am looking forcolony stimulating factor

I am looking forvegf

I am looking fortyrosine

I am looking forvascular endothelial growth factor

I am looking forcamrelizumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

granulocyte colony stimulating factor

anticoagulant therapy

follicular lymphoma grade iiib

oral contraceptives

b-cell lymphoma

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2). This study aims to collect clinical, radiological and histopathology imaging including detailed radiological data, survival data, clinical parameters, molecular pathology and images of HE slices …

liver metastasis

metastasis

glioma

apatinib

neutrophil count

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.